Murilo Abud1, Petr Baranov2, Caroline Hicks3, Sara Patel3, Burke Lieppman2, Caio Regatieri4, John Sinden3, David Isaac5, Marcos Avila5, Michael Young2. 1. Schepens Eye Research Institute, Massachusetts Eye and Ear, an affiliate of Harvard Medical School, Boston, MA, USA ; Federal University of Goias, Goiania, Brazil. 2. Schepens Eye Research Institute, Massachusetts Eye and Ear, an affiliate of Harvard Medical School, Boston, MA, USA. 3. ReNeuron, UK. 4. Federal University of Sao Paulo, Sao Paulo, Brazil. 5. Federal University of Goias, Goiania, Brazil.
Abstract
PURPOSE: The development of photoreceptor replacement therapy for retinal degenerative disorders requires the identification of the optimal cell source and immunosuppressive regimen in a large animal model. Allotransplants are not acutely rejected in swine subretinal space, although it is not known if survival can be improved with immunosuppression. Here we investigated the survival and integration of expanded pig retinal progenitor cells (pRPCs) in normal recipients with and without transient anti-inflammatory suppression. METHODS: pRPCs were derived from the neural retina of E60 GFP transgenic pigs, expanded for six passages, characterized, and transplanted into the subretinal space of 12 pigs. Six recipients received a single intravitreal injection of rapamycin and dexamethasone. RESULTS: pRPCs expressed the photoreceptor development genes Sox2, Pax6, Lhx2, Crx, Nrl, and Recoverin in vitro. Transplanted cells were identified in 9 out of 12 recipients 4 weeks after the injection. pRPCs integrated primarily into the photoreceptor inner segment layer and outer nuclear layer with single cells present in the inner nuclear layer. Donor cells remained recoverin-positive and acquired rhodopsin. We did not observe any signs of graft proliferation. The immunosuppression did not affect the survival or distribution of grafts. No macrophage infiltration or loss of retinal structure was observed in either group. CONCLUSIONS: Local immunosuppression with rapamycin and dexamethasone does not improve the outcome of pRPC allotransplantation into the subretinal space. TRANSLATIONAL RELEVANCE: Survival and integration of pRPC together with the lack of graft proliferation suggests that allogeneic RPC transplantation without transient immunosuppression is a favorable approach for photoreceptor cell replacement.
PURPOSE: The development of photoreceptor replacement therapy for retinal degenerative disorders requires the identification of the optimal cell source and immunosuppressive regimen in a large animal model. Allotransplants are not acutely rejected in swine subretinal space, although it is not known if survival can be improved with immunosuppression. Here we investigated the survival and integration of expanded pig retinal progenitor cells (pRPCs) in normal recipients with and without transient anti-inflammatory suppression. METHODS: pRPCs were derived from the neural retina of E60 GFP transgenic pigs, expanded for six passages, characterized, and transplanted into the subretinal space of 12 pigs. Six recipients received a single intravitreal injection of rapamycin and dexamethasone. RESULTS: pRPCs expressed the photoreceptor development genes Sox2, Pax6, Lhx2, Crx, Nrl, and Recoverin in vitro. Transplanted cells were identified in 9 out of 12 recipients 4 weeks after the injection. pRPCs integrated primarily into the photoreceptor inner segment layer and outer nuclear layer with single cells present in the inner nuclear layer. Donor cells remained recoverin-positive and acquired rhodopsin. We did not observe any signs of graft proliferation. The immunosuppression did not affect the survival or distribution of grafts. No macrophage infiltration or loss of retinal structure was observed in either group. CONCLUSIONS: Local immunosuppression with rapamycin and dexamethasone does not improve the outcome of pRPC allotransplantation into the subretinal space. TRANSLATIONAL RELEVANCE: Survival and integration of pRPC together with the lack of graft proliferation suggests that allogeneic RPC transplantation without transient immunosuppression is a favorable approach for photoreceptor cell replacement.
Authors: Maria Voss Kyhn; Jens F Kiilgaard; Ana Garcia Lopez; Erik Scherfig; Jan U Prause; Morten la Cour Journal: Acta Ophthalmol Date: 2007-10-18 Impact factor: 3.761
Authors: R E MacLaren; R A Pearson; A MacNeil; R H Douglas; T E Salt; M Akimoto; A Swaroop; J C Sowden; R R Ali Journal: Nature Date: 2006-11-09 Impact factor: 49.962
Authors: Budd A Tucker; In-Hyun Park; Sara D Qi; Henry J Klassen; Caihui Jiang; Jing Yao; Stephen Redenti; George Q Daley; Michael J Young Journal: PLoS One Date: 2011-04-29 Impact factor: 3.240
Authors: H Klassen; J F Kiilgaard; K Warfvinge; M S Samuel; R S Prather; F Wong; R M Petters; M la Cour; M J Young Journal: Stem Cells Int Date: 2012-04-09 Impact factor: 5.443
Authors: Murilo Batista Abud; Petr Baranov; Sara Patel; Caroline A Hicks; David Leonardo Cruvinel Isaac; Ricardo Noguera Louzada; Pierre Dromel; Deepti Singh; John Sinden; Marcos P Ávila; Michael Young Journal: J Cell Mol Med Date: 2022-04-28 Impact factor: 5.295